Peter Vandenberghe
Overview
Explore the profile of Peter Vandenberghe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
6885
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lierman E, Smits S, Debackere K, Andre M, Michaux L, Vandenberghe P
Br J Haematol
. 2022 Nov;
200(5):665-668.
PMID: 36385372
No abstract available.
12.
Valent P, Klion A, Roufosse F, Simon D, Metzgeroth G, Leiferman K, et al.
Allergy
. 2022 Oct;
78(1):47-59.
PMID: 36207764
Eosinophilia and eosinophil activation are recurrent features in various reactive states and certain hematologic malignancies. In patients with hypereosinophilia (HE), HE-induced organ damage is often encountered and may lead to...
13.
Che H, Jatsenko T, Lenaerts L, Dehaspe L, Vancoillie L, Brison N, et al.
Clin Chem
. 2022 Jun;
68(9):1164-1176.
PMID: 35769009
Background: Cell-free DNA (cfDNA) analysis holds great promise for non-invasive cancer screening, diagnosis, and monitoring. We hypothesized that mining the patterns of cfDNA shallow whole-genome sequencing datasets from patients with...
14.
Delforge M, Raddoux J, Antonis C, Clement C, Kint N, Vanhellemont A, et al.
Onco Targets Ther
. 2022 Mar;
15:243-250.
PMID: 35310960
Purpose: Multiple myeloma (MM) patients with triple- and penta-refractory disease have a poor survival and limited treatment options. Selinexor, in combination with bortezomib and dexamethasone, demonstrated clinical activity in the...
15.
Verbesselt M, Meekers E, Vandenberghe P, Delforge M, Vandenbriele C
Eur Heart J Case Rep
. 2022 Mar;
6(3):ytac093.
PMID: 35274077
Background: Drug-induced myocarditis is a rare complication of certain cancer treatments, characterized by the development of myocardial inflammation shortly after initiation of treatment, potentially leading to heart failure and/or malignant...
16.
Ieven T, Vandebotermet M, Nuyttens L, Devolder D, Vandenberghe P, Bullens D, et al.
Vaccines (Basel)
. 2022 Feb;
10(2).
PMID: 35214744
The reported incidence of immediate hypersensitivity reactions (IHR) including anaphylaxis after COVID-19 vaccination is 10-fold higher than for other vaccines. Several patient groups are theorized to be at particular risk....
17.
Locke F, Miklos D, Jacobson C, Perales M, Kersten M, Oluwole O, et al.
N Engl J Med
. 2021 Dec;
386(7):640-654.
PMID: 34891224
Background: The prognosis of patients with early relapsed or refractory large B-cell lymphoma after the receipt of first-line chemoimmunotherapy is poor. Methods: In this international, phase 3 trial, we randomly...
18.
Keszei M, Record J, Kritikou J, Wurzer H, Geyer C, Thiemann M, et al.
J Clin Invest
. 2021 Dec;
131(23).
PMID: 34850746
No abstract available.
19.
He M, Saeed M, Record J, Keszei M, Pinho L, Vasconcelos-Fontes L, et al.
J Allergy Clin Immunol
. 2021 Aug;
149(3):1069-1084.
PMID: 34384840
Background: B-cell affinity maturation in germinal center relies on regulated actin dynamics for cell migration and cell-to-cell communication. Activating mutations in the cytoskeletal regulator Wiskott-Aldrich syndrome protein (WASp) cause X-linked...
20.
Peeters M, Geusens J, Van der Cruyssen F, Michaux L, de Leval L, Tousseyn T, et al.
Pathol Oncol Res
. 2021 Jul;
27:642433.
PMID: 34257608
Non-Hodgkin lymphomas comprise a heterogeneous group of malignancies, with a wide scope of clinical, radiological and histological presentations. In this paper, a case is presented of a 59-year-old white male...